Hence, repression of AP-2 function resulted in increased sensitivity towards ionizing radiation and we conclude that expression of AP-2 genes might confer a selective advantage to breast tumor cells towards chemotherapeutic agents and irradiation. The gene discussed is TFAP2A; the disease is breast neoplasm.